X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1119) 1119
Book Review (223) 223
Publication (121) 121
Magazine Article (7) 7
Book / eBook (5) 5
Conference Proceeding (4) 4
Book Chapter (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1114) 1114
index medicus (1045) 1045
male (867) 867
female (732) 732
anus neoplasms - virology (636) 636
adult (579) 579
middle aged (524) 524
cancer (443) 443
human papillomavirus (366) 366
anus neoplasms - pathology (355) 355
anal cancer (314) 314
anus neoplasms - epidemiology (304) 304
aged (298) 298
papillomavirus infections - complications (291) 291
risk factors (283) 283
oncology (272) 272
prevalence (267) 267
infectious diseases (259) 259
hiv infections - complications (257) 257
papillomavirus infections - virology (245) 245
hiv (243) 243
papillomavirus infections (217) 217
papillomavirus infections - epidemiology (215) 215
papillomaviridae - isolation & purification (192) 192
anus neoplasms - diagnosis (187) 187
carcinoma, squamous cell - virology (183) 183
men (178) 178
immunology (176) 176
papillomaviridae - genetics (171) 171
aids/hiv (166) 166
anus neoplasms - prevention & control (165) 165
human-papillomavirus infection (164) 164
infection (162) 162
homosexuality, male (159) 159
lesions (156) 156
hpv (153) 153
incidence (148) 148
abridged index medicus (139) 139
anal canal - pathology (139) 139
carcinoma in situ - virology (138) 138
cervical cancer (138) 138
women (138) 138
young adult (136) 136
adolescent (135) 135
neoplasia (130) 130
carcinoma, squamous cell - pathology (128) 128
squamous intraepithelial lesions (128) 128
health aspects (127) 127
papillomavirus infections - prevention & control (127) 127
risk (127) 127
squamous-cell carcinoma (123) 123
papillomavirus infections - pathology (122) 122
aged, 80 and over (119) 119
anal canal - virology (118) 118
research (118) 118
uterine cervical neoplasms - virology (116) 116
retrospective studies (115) 115
active antiretroviral therapy (114) 114
diagnosis (114) 114
surgery (113) 113
anus neoplasms - therapy (112) 112
squamous cell carcinoma (110) 110
anal intraepithelial neoplasia (109) 109
anus neoplasms - etiology (109) 109
intraepithelial neoplasia (109) 109
epidemiology (107) 107
papillomavirus infections - diagnosis (107) 107
carcinoma (106) 106
human immunodeficiency virus--hiv (106) 106
sex (106) 106
biopsy (105) 105
cervical-cancer (104) 104
united-states (102) 102
carcinoma in situ - pathology (101) 101
anus (100) 100
dysplasia (99) 99
human-immunodeficiency-virus (99) 99
anus neoplasms - complications (98) 98
infections (97) 97
risk-factors (97) 97
aids (93) 93
pathology (93) 93
papillomaviridae (91) 91
dna, viral - analysis (90) 90
human-papillomavirus (90) 90
condylomata acuminata - virology (85) 85
analysis (84) 84
polymerase chain reaction (84) 84
sexual behavior (83) 83
article (82) 82
cytology (82) 82
virology (82) 82
cohort studies (81) 81
carcinoma, squamous cell - epidemiology (80) 80
anus diseases - virology (78) 78
care and treatment (77) 77
prevention (76) 76
treatment outcome (76) 76
tumor virus infections - complications (76) 76
genotype (75) 75
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1080) 1080
French (17) 17
Spanish (9) 9
German (7) 7
Danish (5) 5
Czech (4) 4
Portuguese (3) 3
Italian (2) 2
Russian (2) 2
Croatian (1) 1
Dutch (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 02/2013, Volume 105, Issue 3, pp. 175 - 201
The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American... 
United States - epidemiology | Age Distribution | Asian Americans - statistics & numerical data | Humans | Uterine Cervical Neoplasms - epidemiology | Cost of Illness | Anus Neoplasms - virology | Hispanic Americans - statistics & numerical data | Male | Neoplasms - prevention & control | Cause of Death | Incidence | Indians, North American - statistics & numerical data | Penile Neoplasms - epidemiology | Neoplasms - virology | Neoplasms - ethnology | Female | Anus Neoplasms - epidemiology | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - virology | Papillomavirus Infections - complications | SEER Program | Papanicolaou Test | Papillomavirus Infections - epidemiology | Neoplasms - mortality | Papillomavirus Infections - ethnology | Vulvar Neoplasms - virology | Mortality - trends | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Vaginal Smears - statistics & numerical data | Alphapapillomavirus | Oropharyngeal Neoplasms - epidemiology | African Americans - statistics & numerical data | Oceanic Ancestry Group - statistics & numerical data | Vaginal Neoplasms - epidemiology | Adolescent | Vulvar Neoplasms - epidemiology | Sex Distribution | Uterine Cervical Neoplasms - virology | Neoplasms - epidemiology | Prevention | Control | Forecasts and trends | Papillomavirus infections | Patient outcomes | Mortality | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 8/2009, Volume 101, Issue 16, pp. 1120 - 1130
Background Although risk of human papillomavirus (HPV)-associated cancers of the anus, cervix, oropharynx, penis, vagina, and vulva is increased among persons... 
POSITIVE WOMEN | UNITED-STATES | SQUAMOUS INTRAEPITHELIAL LESIONS | ONCOLOGY | ACTIVE ANTIRETROVIRAL THERAPY | ANAL CANCER | ADULTS | HIV-INFECTED PERSONS | HUMAN-IMMUNODEFICIENCY-VIRUS | NATURAL-HISTORY | CELL COUNT | United States - epidemiology | Tumor Virus Infections - virology | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - virology | Male | Incidence | CD4-Positive T-Lymphocytes - immunology | Penile Neoplasms - epidemiology | Acquired Immunodeficiency Syndrome - immunology | HIV Infections - immunology | Neoplasms - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Retrospective Studies | Anus Neoplasms - epidemiology | Tumor Virus Infections - epidemiology | Penile Neoplasms - virology | Papillomavirus Infections - complications | Risk Assessment | Papillomavirus Infections - epidemiology | Risk Factors | Vulvar Neoplasms - virology | CD4 Lymphocyte Count | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Tumor Virus Infections - complications | Alphapapillomavirus | Antiretroviral Therapy, Highly Active | Oropharyngeal Neoplasms - epidemiology | Vaginal Neoplasms - epidemiology | HIV Infections - complications | Vulvar Neoplasms - epidemiology | Uterine Cervical Neoplasms - virology | HIV Infections - drug therapy | Poisson Distribution | Aged | Immunocompromised Host | Acquired Immunodeficiency Syndrome - complications | Research Design | Neoplasms - epidemiology | Immunosuppression | Usage | AIDS (Disease) | Research | Diagnosis | Papillomavirus infections | Health aspects | Risk factors | Cancer | Human papillomavirus | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, Issue 13, pp. 1732 - 1741
Abstract Objective Human papillomavirus (HPV) vaccines can potentially control cervical cancer and help to reduce other HPV-related cancers. We aimed to... 
Hematology, Oncology and Palliative Medicine | Papillomavirus vaccines | Human papillomavirus | Vulvar neoplasms | Vaginal neoplasms | Uterine cervical neoplasms | Precancerous conditions | Anus neoplasms | INFECTIONS | Uterine cervical neo-plasms | VACCINE | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | WORLDWIDE | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | INVASIVE CERVICAL-CANCER | VULVA | Predictive Value of Tests | Age Distribution | Age Factors | Humans | Middle Aged | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Papillomaviridae - genetics | Papillomavirus Infections - diagnosis | Uterine Cervical Dysplasia - diagnosis | Young Adult | Papillomaviridae - immunology | Uterine Cervical Dysplasia - virology | Vaginal Neoplasms - prevention & control | Aged, 80 and over | Adult | Female | Papillomavirus Infections - virology | Vulvar Neoplasms - diagnosis | Retrospective Studies | Uterine Cervical Neoplasms - diagnosis | Cross-Sectional Studies | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Vulvar Neoplasms - virology | Uterine Cervical Dysplasia - prevention & control | Vaginal Neoplasms - virology | Cervical Intraepithelial Neoplasia - virology | Anus Neoplasms - diagnosis | Papillomavirus Infections - prevention & control | Papillomaviridae - classification | Vulvar Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Aged | Human Papillomavirus DNA Tests | DNA, Viral - genetics | Vaginal Neoplasms - diagnosis | Papillomaviruses | Genetic aspects | Papillomavirus infections | Cervical cancer | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 01/2018, Volume 124, Issue 1, pp. 203 - 211
Five‐year relative survival is highest for patients who have vulvar and anal cancers and lowest for those who have penile and oropharyngeal cancers compared... 
human papillomavirus (HPV) cancer | relative survival | HPV‐associated cancer | HPV-associated cancer | UNITED-STATES | HEAD | POPULATION | PREVALENCE | NECK-CANCER | ONCOLOGY | OROPHARYNGEAL CANCER | SQUAMOUS-CELL CARCINOMA | SURVEILLANCE | BURDEN | INCIDENCE TRENDS | Head and Neck Neoplasms - virology | Age Factors | United States | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | African Americans | Anus Neoplasms - virology | Male | Incidence | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Rectal Neoplasms - virology | Adult | Female | Papillomavirus Infections - virology | Uterine Cervical Neoplasms - mortality | Vulvar Neoplasms - mortality | Databases, Factual | Penile Neoplasms - mortality | Penile Neoplasms - virology | Papillomavirus Infections - epidemiology | Vulvar Neoplasms - virology | European Continental Ancestry Group | Survival Rate | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Rectal Neoplasms - mortality | Vaginal Neoplasms - mortality | Anus Neoplasms - mortality | Uterine Cervical Neoplasms - virology | Papillomaviridae | Head and Neck Neoplasms - mortality | Prevention | Cancer patients | Diagnosis | Anal cancer | Cervical cancer | Squamous cell carcinoma | Invasiveness | Vaccination | Sex | Vagina | Vaccines | Cervix | Patients | Survival | Public domain | Screening | Demographics | Human papillomavirus | Penis | Race | Rectum | Cervical carcinoma | Age | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 12/2013, Volume 13, Issue 12, pp. 3202 - 3209
The authors define specific features, including recipient characteristics, organ transplanted, specific HLA types, and medications, associated with incidence... 
organ transplant cohort | Transplant Cancer Match Study | immunosuppression | HPV‐related cancer | HPV-related cancer | Immunosuppression | Organ transplant cohort | SURGERY | RISK | CERVICAL-CANCER | HUMAN-PAPILLOMAVIRUS | RECIPIENTS | TRANSPLANTATION | SKIN CANCERS | WORLDWIDE | MALIGNANCY | ANAL CANCER | SQUAMOUS-CELL CARCINOMAS | SIROLIMUS | United States - epidemiology | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - virology | Male | Incidence | Penile Neoplasms - epidemiology | Young Adult | Vulvar Neoplasms - complications | Immunosuppression - adverse effects | Adult | Female | Papillomavirus Infections - virology | Registries | Anus Neoplasms - epidemiology | Penile Neoplasms - virology | Papillomavirus Infections - complications | Penile Neoplasms - complications | Papillomavirus Infections - epidemiology | Vulvar Neoplasms - virology | Oropharyngeal Neoplasms - virology | Tacrolimus - adverse effects | Oropharyngeal Neoplasms - complications | Oropharyngeal Neoplasms - epidemiology | Anus Neoplasms - complications | Organ Transplantation - adverse effects | Uterine Cervical Neoplasms - complications | Adolescent | Vulvar Neoplasms - epidemiology | Uterine Cervical Neoplasms - virology | Cohort Studies | Women | Tacrolimus | Transplantation of organs, tissues, etc | Organ transplant recipients | Diagnosis | Health aspects | Papillomavirus infections | Cervical cancer | Cancer | Medical screening | Human papillomavirus | Index Medicus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 5/2012, Volume 205, Issue 10, pp. 1544 - 1553
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 20, pp. 4013 - 4021
Patients with a history of squamous cell carcinoma of the anal canal are at an increased risk of subsequent human papillomavirus‐related second primary... 
human papillomavirus (HPV) | second primary malignancy | anal cancer | Surveillance, Epidemiology, and End Results (SEER) | standardized incidence ratios | UNITED-STATES | DIAGNOSIS | HPV INFECTION | PREVENTION | POPULATION-BASED ANALYSIS | and End Results (SEER) | PREVALENCE | Epidemiology | CERVICAL INTRAEPITHELIAL NEOPLASIA | STRATEGIES | WOMEN | Surveillance | ONCOLOGY | MALIGNANCIES | Genital Neoplasms, Male - epidemiology | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - virology | Male | Risk | Pharyngeal Neoplasms - virology | Genital Neoplasms, Female - epidemiology | Incidence | Genital Neoplasms, Male - virology | Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasms - epidemiology | Aged, 80 and over | Adult | Female | Papillomavirus Infections - virology | Retrospective Studies | Anus Neoplasms - epidemiology | SEER Program | Carcinoma, Squamous Cell - epidemiology | Papillomavirus Infections - epidemiology | Risk Factors | Survivors | Mouth Neoplasms - virology | Genital Neoplasms, Female - virology | Neoplasms, Second Primary - epidemiology | Mouth Neoplasms - epidemiology | Neoplasms, Second Primary - virology | Sex Factors | Pharyngeal Neoplasms - epidemiology | Uterine Cervical Neoplasms - virology | Papillomaviridae | Aged | Complications and side effects | Cancer patients | Care and treatment | Papillomavirus infections | Anal cancer | Risk factors | Squamous cell carcinoma | Identification methods | Health risks | Infections | Medical screening | Pharynx | Patients | Genital cancers | Confidence intervals | Oral cavity | Human papillomavirus | Anus | Men | Health risk assessment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 05/2017, Volume 41, Issue 5, pp. 607 - 615
Dysregulated expression of oncogenic types of E6 and E7 is necessary for human papillomavirus (HPV)-driven carcinogenesis. An HPV E6/E7 mRNA in situ... 
High-grade squamous intraepithelial lesion | Low-grade squamous intraepithelial lesion | Human papillomavirus | RNA | Cervical intraepithelial neoplasia | CIN | Cervical carcinoma | Oropharyngeal carcinoma | In situ hybridization | HPV | SURGERY | DIAGNOSIS | low-grade squamous intraepithelial lesion | ASCUS-LSIL TRIAGE | cervical carcinoma | INTRAEPITHELIAL LESIONS | HUMAN-PAPILLOMAVIRUS | PATHOLOGY | oropharyngeal carcinoma | cervical intraepithelial neoplasia | HIGH-RISK HPV | CERVIX | P16 | human papillomavirus | SQUAMOUS-CELL CARCINOMA | GRADE | high-grade squamous intraepithelial lesion | EXPRESSION | in situ hybridization | Immunohistochemistry | Predictive Value of Tests | Cervical Intraepithelial Neoplasia - pathology | Head and Neck Neoplasms - virology | Humans | Anus Neoplasms - virology | Uterine Cervical Neoplasms - pathology | Papillomavirus E7 Proteins - genetics | Papillomavirus Infections - pathology | Head and Neck Neoplasms - chemistry | Vulvar Neoplasms - pathology | Cyclin-Dependent Kinase Inhibitor p16 - analysis | In Situ Hybridization | Neoplasm Grading | RNA, Viral - genetics | Polymerase Chain Reaction | Anus Neoplasms - chemistry | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Reproducibility of Results | Biomarkers, Tumor - analysis | RNA, Messenger - genetics | Cervical Intraepithelial Neoplasia - chemistry | Vulvar Neoplasms - virology | Anus Neoplasms - pathology | Uterine Cervical Neoplasms - genetics | Cervical Intraepithelial Neoplasia - virology | Head and Neck Neoplasms - pathology | Papillomavirus Infections - genetics | Vulvar Neoplasms - genetics | Anus Neoplasms - genetics | Uterine Cervical Neoplasms - virology | Head and Neck Neoplasms - genetics | Biomarkers, Tumor - genetics | Cervical Intraepithelial Neoplasia - genetics | Human Papillomavirus DNA Tests | Uterine Cervical Neoplasms - chemistry | Observer Variation | Vulvar Neoplasms - chemistry | Index Medicus
Journal Article
Journal Article